Rakht Brahmand: Samantha Ruth Prabhu Excited To Be Back On Sets Amid Myositis Treatment
After Samantha Ruth Prabhu’s diagnosis with auto-immune disease, the actress has been focusing on her health and taking up ...
BollywoodShaadis7d
Samantha Ruth Prabhu Reveals How Strong Myositis Medicines Affected Her Skin, 'Dryness, Puffiness..'
Samantha Ruth Prabhu, who has been dealing with myositis, recently revealed that when she fell sick, she had to take strong ...
I've Become More Mindful of My Skin, Says Samantha
Actress Samantha Ruth Prabhu says she is a lot more ‘skin sensible’ and shared that when she fell sick and had to take strong ...
I’m more ‘skin sensible’ after illness, medications: Samantha
Samantha, who disclosed her Myositis diagnosis in 2022, recently shared close-up images of herself on Instagram. She also ...
Samantha Ruth Prabhu recalls 'strong medications' affecting her skin; reveals her non-invasive routine to maintain glowing skin
Samantha Ruth Prabhu opens up about her skin health journey following her Myositis diagnosis, sharing her non-invasive ...
In fight of his life, UCLA’s Rod Foster holds fast to his faith
Rod Foster is battling inclusion body myositis, a disease that has left the player once known as "Rocket Rod" bound to a ...
Pharmabiz12d
US FDA grants rare paediatric disease designation to Cartesian Therapeutics’ Descartes-08 to treat juvenile dermatomyositis
US FDA grants rare paediatric disease designation to Cartesian Therapeutics’ Descartes-08 to treat juvenile dermatomyositis: Gaithersburg, Maryland Tuesday, September 10, 2024, ...
Spotlight on Interstitial Lung Disease Diagnosis and Treatment on ILD Day, Sept. 18
Nine leading patient organizations are uniting to present the fourth annual ILD Day on Wednesday, Sept. 18, to raise ...
Cartesian Therapeutics Receives FDA Rare Pediatric Disease Designation for Descartes-08 for the Treatment of Juvenile Dermatomyositis
Descartes-08, Cartesian’s lead mRNA cell therapy candidate, is an autologous mRNA-engineered chimeric antigen receptor T-cell therapy (mRNA CAR-T) product candidate targeting B-cell maturation antigen ...
Cartesian Therapeutics Gets FDA Rare Pediatric Disease Designation for Dermatomyositis Treatment
Cartesian Therapeutics said it has received rare pediatric disease designation from the U.S. Food and Drug Administration for its Descartes-08 treatment of juvenile dermatomyositis.
CBS News19d
Breast cancer rises among Asian American and Pacific Islander women, and experts aren't sure why
The latest federal data shows the rate of new breast cancer diagnoses in Asian American and Pacific Islander women — a group that once had relatively low rates of diagnosis — is rising much ...